CAMBRIDGE, Mass., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused…
A new partnership brings together a validated discovery platform and cutting-edge computational innovation in targeted protein degradationVIENNA and LAUSANNE, Switzerland,…
TARPON SPRINGS, Fla., August 26, 2025 -- Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase…
Company advancing U.S. commercialization with FDA-approved ketamine and rare disorder NDA filingsTORONTO, Aug. 26, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings…
TEL AVIV, Israel, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a…
Targeting the Multi-Trillion Dollar Longevity Market Jupiter, Florida, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (“Jupiter”…
Announced unprecedented Phase 1b/2a topline results in chronic spinal cord injury NVG-291 is the first pharmacologic candidate to demonstrate statistically…
PALO ALTO, CALIFORNIA / ACCESS Newswire / August 26, 2025 / Bioz, Inc., a leader in AI-powered scientific literature analysis…
DETROIT, MI / ACCESS Newswire / August 25, 2025 / Muzzammil Riaz, a registered nurse and wellness advocate, believes that…
CARY, N.C., Aug. 25, 2025 /PRNewswire/ -- WCG, a global leader in providing solutions that measurably improve and accelerate clinical…